Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 213,500
-5,000 (-2.29%)
Last updated: Jan 29, 2026, 12:09 PM KST
Celltrion Market Cap
Celltrion has a market cap or net worth of 46.93 trillion as of January 29, 2026. Its market cap has increased by 16.27% in one year.
Market Cap
46.93T
Enterprise Value
49.01T
Revenue
3.90T
Ranking
n/a
PE Ratio
64.74
Stock Price
213,500.00
Market Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 46.93T, an increase of 45,112.44%. That is a compound annual growth rate of 41.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 47.81T | 20.72% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| ALTEOGEN | 21.71T |
| SK Biopharmaceuticals | 9.35T |
| HLB Co., Ltd. | 8.38T |
| LigaChem Biosciences | 6.76T |
| Peptron | 6.53T |
| PharmaResearch | 5.10T |
| D&D Pharmatech | 4.22T |